Brainify.AI is an AI biomarker platform for the development of novel treatments for depression that increases the likelihood of new treatment approval and increases drug efficacy. We are members of J&J Labs and Merck DSS. Brainify.AI is backed by Merck GHI Fund, Northpond, and Kodori VC